Grant Pickering, Director, Chief Executive Officer, on June 18, 2026, sold 24,461 shares in Vaxcyte (PCVX) for $1,284,205. Following the Form 4 filing with the SEC, Pickering has control over a total of 609,918 common shares of the company, with 474,703 shares held directly and 135,215 controlled indirectly.
SEC Filing: